Detection of plasma tumor DNA (ptDNA) in patients with hormone receptor-positive HER2-negative (HR+HER2-) early breast cancer (EBC) in clinical remission

被引：0
|
作者：
Shah, M.
Hunter, N.
Ensminger, J.
Shinn, D.
Cole, A. J.
Quinn, H. E.
Edelstein, D. L.
Wang, C.
Smith, K. L.
Richardson, A. L.
Cimino-Mathews, A.
Wolff, A. C.
Cravero, K.
Park, B. H.
Stearns, V.
机构：
[1] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Sysmex Inost, Baltimore, MD USA
[3] Johns Hopkins Med, Baltimore, MD USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P4-01-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-01-16
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PATTERNS OF CLINICAL MANAGEMENT AND RESOURCE UTILIZATION FOR POSTMENOPAUSAL HORMONE RECEPTOR-POSITIVE HER2-NEGATIVE (HR+HER2-) ADVANCED BREAST CANCER (ABC) IN EUROPE
    Andre, F.
    Marinsek, N.
    Ricci, J. F.
    Etchberger, J.
    Degun, R.
    Benelli, G.
    Saletan, S.
    Jerusalem, G.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A419 - A419
  • [2] EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
    K. Almstedt
    S. Mendoza
    M. Otto
    M. J. Battista
    J. Steetskamp
    A. S. Heimes
    S. Krajnak
    A. Poplawski
    A. Gerhold-Ay
    A. Hasenburg
    C. Denkert
    M. Schmidt
    [J]. Breast Cancer Research and Treatment, 2020, 182 : 137 - 146
  • [3] Management of hormone receptor-positive, HER2-negative early breast cancer
    Walsh, Elaine M.
    Smith, Karen L.
    Stearns, Vered
    [J]. SEMINARS IN ONCOLOGY, 2020, 47 (04) : 187 - 200
  • [4] Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
    Ditsch, Nina
    Schmidt, Marcus
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2019, 79 (12) : 1328 - 1335
  • [5] EndoPredict(R) in early hormone receptor-positive, HER2-negative breast cancer
    Almstedt, K.
    Mendoza, S.
    Otto, M.
    Battista, M. J.
    Steetskamp, J.
    Heimes, A. S.
    Krajnak, S.
    Poplawski, A.
    Gerhold-Ay, A.
    Hasenburg, A.
    Denkert, C.
    Schmidt, M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (01) : 137 - 146
  • [6] Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
    Cantini, Luca
    Trapani, Dario
    Guidi, Lorenzo
    Bielo, Luca Boscolo
    Scafetta, Roberta
    Koziej, Marcin
    Vidal, Laura
    Saini, Kamal S.
    Curigliano, Giuseppe
    [J]. CANCER TREATMENT REVIEWS, 2024, 123
  • [7] Molecular classification of hormone receptor-positive HER2-negative breast cancer
    Jin, Xi
    Zhou, Yi-Fan
    Ma, Ding
    Zhao, Shen
    Lin, Cai-Jin
    Xiao, Yi
    Fu, Tong
    Liu, Cheng-Lin
    Chen, Yi-Yu
    Xiao, Wen-Xuan
    Liu, Ya-Qing
    Chen, Qing-Wang
    Yu, Ying
    Shi, Le-Ming
    Shi, Jin-Xiu
    Huang, Wei
    Robertson, John F. R.
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    [J]. NATURE GENETICS, 2023, 55 (10) : 1696 - +
  • [8] Molecular classification of hormone receptor-positive HER2-negative breast cancer
    Xi Jin
    Yi-Fan Zhou
    Ding Ma
    Shen Zhao
    Cai-Jin Lin
    Yi Xiao
    Tong Fu
    Cheng-Lin Liu
    Yi-Yu Chen
    Wen-Xuan Xiao
    Ya-Qing Liu
    Qing-Wang Chen
    Ying Yu
    Le-Ming Shi
    Jin-Xiu Shi
    Wei Huang
    John F. R. Robertson
    Yi-Zhou Jiang
    Zhi-Ming Shao
    [J]. Nature Genetics, 2023, 55 : 1696 - 1708
  • [9] The clinical impact of NOLUS in unresectable/metastatic hormone receptor-positive (HR+)/HER2-negative breast cancer
    Tajiri, Wakako
    Nakamura, Yoshiaki
    Kawasaki, Junji
    Koi, Yumiko
    Akiyoshi, Sayuri
    Koga, Chinami
    Tokunaga, Eriko
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [10] PATTERNS OF CLINICAL MANAGEMENT AND RESOURCE UTILIZATION FOR POSTMENOPAUSAL HORMONE-RECEPTOR-POSITIVE HER2-NEGATIVE (HR+HER2-) ADVANCED BREAST CANCER (ABC) IN EUROPE
    Jerusalem, G.
    Marinsek, N.
    Ricci, J.
    Etchberger, J.
    Degun, R.
    Benelli, G.
    Saletan, S.
    Andre, F.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 122 - 122
12345